Variant report

Variant	nsv427744
Chromosome Location	chr6:5061006-5073109
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:5068153-5068988	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:5061184-5061881	HepG2	liver:	n/a	chr6:5061336-5061352 chr6:5061337-5061353
3	BATF	chr6:5070104-5070318	GM12878	blood:	n/a	n/a
4	BHLHE40	chr6:5068350-5068896	HepG2	liver:	n/a	chr6:5068537-5068553
5	BHLHE40	chr6:5061449-5061672	HepG2	liver:	n/a	n/a
6	BHLHE40	chr6:5063171-5063209	K562	blood:	n/a	n/a
7	BHLHE40	chr6:5061459-5061709	HepG2	liver:	n/a	n/a
8	BHLHE40	chr6:5061410-5061732	HepG2	liver:	n/a	n/a
9	BRCA1	chr6:5068421-5068853	HepG2	liver:	n/a	chr6:5068421-5068428
10	CEBPB	chr6:5068311-5068963	HepG2	liver:	n/a	n/a
11	CEBPB	chr6:5062025-5062220	K562	blood:	n/a	chr6:5062158-5062169
12	CEBPB	chr6:5061408-5062298	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629 chr6:5062158-5062169
13	CEBPB	chr6:5061517-5061804	MCF-7	breast:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
14	CEBPB	chr6:5061479-5061817	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
15	CEBPB	chr6:5066825-5067162	HepG2	liver:	n/a	n/a
16	CEBPB	chr6:5061422-5061903	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
17	CEBPB	chr6:5061442-5061749	HepG2	liver:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
18	CEBPB	chr6:5068292-5068755	HepG2	liver:	n/a	n/a
19	CEBPB	chr6:5061423-5061868	Hela-S3	cervix:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
20	CEBPB	chr6:5066870-5067148	A549	lung:	n/a	n/a
21	CEBPB	chr6:5061371-5061803	MCF-7	breast:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
22	CEBPB	chr6:5061436-5061774	IMR90	lung:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
23	CEBPB	chr6:5068413-5068896	HepG2	liver:	n/a	n/a
24	CEBPB	chr6:5061440-5061771	A549	lung:	n/a	chr6:5061596-5061607 chr6:5061618-5061629
25	CEBPD	chr6:5068332-5068958	HepG2	liver:	n/a	n/a
26	CEBPD	chr6:5061440-5061760	HepG2	liver:	n/a	n/a
27	CHD2	chr6:5068338-5068924	HepG2	liver:	n/a	n/a
28	CREB1	chr6:5068113-5069122	HepG2	liver:	n/a	chr6:5068752-5068765
29	CREB1	chr6:5068134-5069127	HepG2	liver:	n/a	chr6:5068752-5068765
30	CTCF	chr6:5068380-5068530	HepG2	liver:	n/a	n/a
31	CTCF	chr6:5068451-5068531	HepG2	liver:	n/a	n/a
32	CTCF	chr6:5067740-5067890	HepG2	liver:	n/a	n/a
33	CTCF	chr6:5067804-5067822	GM13976	blood:	n/a	n/a
34	CTCF	chr6:5068440-5068590	Caco-2	colon:	n/a	n/a
35	CTCF	chr6:5067832-5067838	GM13976	blood:	n/a	n/a
36	CTCF	chr6:5068374-5068674	HepG2	liver:	n/a	n/a
37	EBF1	chr6:5072761-5073024	GM12878	blood:	n/a	n/a
38	ELF1	chr6:5068318-5068898	HepG2	liver:	n/a	n/a
39	ELF1	chr6:5068266-5068917	HepG2	liver:	n/a	n/a
40	EP300	chr6:5061396-5061784	HepG2	liver:	n/a	chr6:5061424-5061438
41	EP300	chr6:5061497-5061744	Hela-S3	cervix:	n/a	n/a
42	EP300	chr6:5061377-5061771	HepG2	liver:	n/a	chr6:5061424-5061438
43	EP300	chr6:5068153-5068948	HepG2	liver:	n/a	chr6:5068514-5068524 chr6:5068295-5068309
44	EP300	chr6:5061456-5061783	HepG2	liver:	n/a	n/a
45	EP300	chr6:5068261-5068903	HepG2	liver:	n/a	chr6:5068514-5068524 chr6:5068295-5068309
46	EP300	chr6:5068272-5069002	HepG2	liver:	n/a	chr6:5068514-5068524 chr6:5068295-5068309
47	FOS	chr6:5061450-5061700	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr6:5063331-5063444	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr6:5061436-5061685	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr6:5061438-5061637	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:5066994-5067044	IMR90	lung:	fetal
2	chr6:5067092-5067142	PANC-1	pancreas:	n/a
3	chr6:5066984-5067034	ovcar-3	ovarian:	n/a
4	chr6:5068684-5068734	SK-N-SH_RA	brain:	n/a
5	chr6:5066984-5067034	PrEC	prostate:	n/a
6	chr6:5067092-5067142	LNCaP	prostate:	n/a
7	chr6:5066984-5067034	HepG2	liver:	n/a
8	chr6:5066984-5067034	U87	brain:	n/a
9	chr6:5066994-5067044	T-47D	breast:	n/a
10	chr6:5068684-5068734	AG04449	skin:	fetal
11	chr6:5068684-5068734	HUVEC	blood vessel:	n/a
12	chr6:5068684-5068734	MCF-7	breast:	n/a
13	chr6:5066984-5067034	MCF10A-Er-Src	breast:	n/a
14	chr6:5068684-5068734	Jurkat	blood:	n/a
15	chr6:5067092-5067142	HCF	heart:	n/a
16	chr6:5066984-5067034	GM12891	blood:	n/a
17	chr6:5067127-5067177	Hepatocyte	liver:	n/a
18	chr6:5066984-5067034	NHBE	bronchial:	n/a
19	chr6:5066984-5067034	HAEpiC	amniotic membrane:	n/a
20	chr6:5066994-5067044	PANC-1	pancreas:	n/a
21	chr6:5066994-5067044	GM06990	blood:	n/a
22	chr6:5066984-5067034	HNPCEpiC	eye:	n/a
23	chr6:5067127-5067177	SK-N-SH_RA	brain:	n/a
24	chr6:5067092-5067142	Caco-2	colon:	n/a
25	chr6:5068684-5068734	LNCaP	prostate:	n/a
26	chr6:5066984-5067034	A549	lung:	n/a
27	chr6:5068684-5068734	HMEC	breast:	n/a
28	chr6:5067092-5067142	AG10803	skin:	n/a
29	chr6:5066994-5067044	NT2-D1	testis:	n/a
30	chr6:5066994-5067044	LNCaP	prostate:	n/a
31	chr6:5067127-5067177	ProgFib	skin:	n/a
32	chr6:5068684-5068734	SK-N-SH	brain:	n/a
33	chr6:5068684-5068734	BJ	skin:	n/a
34	chr6:5067127-5067177	HRPEpiC	eye:	n/a
35	chr6:5067092-5067142	MCF-7	breast:	n/a
36	chr6:5067127-5067177	HUVEC	blood vessel:	n/a
37	chr6:5067092-5067142	H1-hESC	embryonic stem cell:	embryo
38	chr6:5067127-5067177	GM06990	blood:	n/a
39	chr6:5068684-5068734	HEK293	kidney:	embryo
40	chr6:5068684-5068734	AoSMC	blood vessel:	n/a
41	chr6:5067127-5067177	K562	blood:	n/a
42	chr6:5068684-5068734	HL-60	blood:	n/a
43	chr6:5066984-5067034	ECC-1	luminal epithelium:	n/a
44	chr6:5067127-5067177	HCT-116	colon:	n/a
45	chr6:5068684-5068734	HRE	kidney:	n/a
46	chr6:5068684-5068734	PANC-1	pancreas:	n/a
47	chr6:5067092-5067142	AG04450	lung:	fetal
48	chr6:5066984-5067034	HRCEpiC	kidney:	n/a
49	chr6:5067092-5067142	NT2-D1	testis:	n/a
50	chr6:5066994-5067044	AG10803	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:5062947..5065809-chr6:5065825..5069416,3	K562	blood:
2	chr6:5063657..5065685-chr6:5065825..5068724,2	K562	blood:
3	chr6:5067584..5069589-chr6:5073200..5075622,2	MCF-7	breast:
4	chr6:5072255..5076149-chr6:5080723..5083422,4	K562	blood:
5	chr6:5067420..5070838-chr6:5082550..5086486,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PPP1R3G-1	chr6:5072827-5072968	ENSG00000251561
2	lnc-LYRM4-2	chr6:5066029-5067216	NONHSAT107511

Variant related genes	Relation type
ENSG00000220685	TF binding region
ENSG00000220685	CpG island
ENSG00000220685	chromatin interactions
ENSG00000219607	chromatin interactions
ARPC5	miRNA target sites

Extended variants
information (count: 490 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:490 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs545929922	chr6:5061011-5061012	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs557944904	chr6:5061031-5061032	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs369708364	chr6:5061042-5061043	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs6923628	chr6:5061115-5061116	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs62386477	chr6:5061117-5061118	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs529214104	chr6:5061126-5061127	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs116770859	chr6:5061176-5061177	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs562916149	chr6:5061292-5061293	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs533209781	chr6:5061313-5061314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs17359522	chr6:5061326-5061327	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs143795638	chr6:5061386-5061387	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs527868125	chr6:5061412-5061413	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs372671492	chr6:5061421-5061422	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs547921252	chr6:5061428-5061429	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs376105270	chr6:5061436-5061437	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs538554290	chr6:5061501-5061502	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs9405253	chr6:5061580-5061581	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs1247000	chr6:5061594-5061595	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs180720272	chr6:5061598-5061599	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs557885507	chr6:5061616-5061617	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs573016980	chr6:5061734-5061735	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs540405924	chr6:5061736-5061737	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs148167511	chr6:5061804-5061805	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs573819578	chr6:5061810-5061811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs544501183	chr6:5061844-5061845	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs6924916	chr6:5061888-5061889	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs371015270	chr6:5061931-5061932	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs569338246	chr6:5061972-5061973	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs545038832	chr6:5061982-5061983	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs9504313	chr6:5062011-5062012	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs60114350	chr6:5062121-5062122	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs185607582	chr6:5062151-5062152	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs561549244	chr6:5062184-5062185	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs531873340	chr6:5062194-5062195	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs114094430	chr6:5062276-5062277	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs2764122	chr6:5062304-5062305	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs139613644	chr6:5062315-5062316	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs35400588	chr6:5062316-5062317	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs9378927	chr6:5062354-5062355	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs112310810	chr6:5062374-5062375	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs371882087	chr6:5062382-5062383	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs557316872	chr6:5062418-5062419	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs56284818	chr6:5062461-5062462	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs533886227	chr6:5062490-5062491	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs34921312	chr6:5062494-5062495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs397754948	chr6:5062497-5062498	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs150254554	chr6:5062541-5062542	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs375722228	chr6:5062545-5062546	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs376825400	chr6:5062566-5062567	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs376552673	chr6:5062639-5062640	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21364760	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
dysmorphism	22105932	CNVD
psychomotor delay	22105932	CNVD
Ovarian cancer	19193619	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:39 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:5055200-5061400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
2	chr6:5058200-5062000	Enhancers	Fetal Intestine Small	intestine
3	chr6:5058600-5063000	Enhancers	Liver	Liver
4	chr6:5058800-5064000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr6:5059800-5064400	Enhancers	HepG2	liver
6	chr6:5060600-5061200	Weak transcription	Fetal Intestine Large	intestine
7	chr6:5061200-5061400	Enhancers	Fetal Intestine Large	intestine
8	chr6:5061400-5062000	Enhancers	Adipose Nuclei	Adipose
9	chr6:5061400-5062200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr6:5062000-5067000	Weak transcription	Fetal Intestine Small	intestine
11	chr6:5063000-5067600	Weak transcription	Liver	Liver
12	chr6:5063400-5063800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr6:5063800-5064200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr6:5064000-5064200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr6:5064200-5067000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr6:5064400-5067400	Weak transcription	HepG2	liver
17	chr6:5065400-5067000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr6:5067000-5067200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr6:5067000-5067400	ZNF genes & repeats	Fetal Intestine Small	intestine
20	chr6:5067200-5067800	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr6:5067200-5068600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
22	chr6:5067400-5067800	ZNF genes & repeats	Brain Hippocampus Middle	brain
23	chr6:5067400-5068200	Enhancers	HepG2	liver
24	chr6:5067400-5074000	Weak transcription	Ovary	ovary
25	chr6:5067600-5068800	Enhancers	Liver	Liver
26	chr6:5067800-5071200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr6:5068000-5068600	Weak transcription	Fetal Intestine Small	intestine
28	chr6:5068200-5068800	Enhancers	Fetal Intestine Large	intestine
29	chr6:5068200-5069000	Enhancers	iPS-15b Cell Line	embryonic stem cell
30	chr6:5068200-5069000	Flanking Active TSS	HepG2	liver
31	chr6:5068600-5068800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr6:5068800-5074200	Weak transcription	Fetal Intestine Large	intestine
33	chr6:5069000-5073000	Enhancers	HepG2	liver
34	chr6:5070800-5071000	Weak transcription	Fetal Intestine Small	intestine
35	chr6:5071000-5071800	Enhancers	Fetal Intestine Small	intestine
36	chr6:5071200-5073000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr6:5071800-5082400	Weak transcription	Fetal Intestine Small	intestine
38	chr6:5072200-5073400	Enhancers	GM12878-XiMat	blood
39	chr6:5073000-5073600	Weak transcription	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links